Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kui Chen

Showing results (491-500 of 503) with videos related to

Pageof 51
Sort By:
Journal of Medicinal Chemistry|February 22, 2011
Discovery and optimization of a series of benzothiazole phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitorsNoel D D'Angelo, Tae-Seong Kim, Kristin Andrews, et al.
Annals of Surgery|December 31, 2025
Plasma Cell-free DNA Methylomes for Hepatocellular Carcinoma Detection and Monitoring After Liver Resection or TransplantationKui Chen, Zhihao Li, Bianca O Kirsh, et al.
Nature Cancer|February 19, 2026
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detectionYong Zeng, Dor D Abelman, Althaf Singhawansa, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular LiabilitiesYuan Cheng, James Brown, Ted C Judd, et al.
Nature|November 15, 2013
Antidiabetic effects of glucokinase regulatory protein small-molecule disruptorsDavid J Lloyd, David J St Jean, Robert J M Kurzeja, et al.
Nature Cancer|December 27, 2023
Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancersMarc Payton, Brian Belmontes, Kelly Hanestad, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of β-SecretaseMatthew R Kaller, Scott S Harried, Brian Albrecht, et al.
Ebiomedicine|June 5, 2019
Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Ca<sub>v</sub>3.2 T-type voltage-gated calcium channels and Ca<sup>2+</sup> influxHugo Jimenez, Minghui Wang, Jacquelyn W Zimmerman, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2015
Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's diseaseJian Jeffrey Chen, Qingyian Liu, Chester Yuan, et al.
Journal of Medicinal Chemistry|April 4, 2012
Design and preparation of a potent series of hydroxyethylamine containing β-secretase inhibitors that demonstrate robust reduction of central β-amyloidMatthew M Weiss, Toni Williamson, Safura Babu-Khan, et al.
Pageof 51

Showing results (491-500 of 503) with videos related to

Sort By:
Pageof 51
Journal of Medicinal Chemistry|February 22, 2011
Discovery and optimization of a series of benzothiazole phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitorsNoel D D'Angelo, Tae-Seong Kim, Kristin Andrews, et al.
Annals of Surgery|December 31, 2025
Plasma Cell-free DNA Methylomes for Hepatocellular Carcinoma Detection and Monitoring After Liver Resection or TransplantationKui Chen, Zhihao Li, Bianca O Kirsh, et al.
Nature Cancer|February 19, 2026
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detectionYong Zeng, Dor D Abelman, Althaf Singhawansa, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular LiabilitiesYuan Cheng, James Brown, Ted C Judd, et al.
Nature|November 15, 2013
Antidiabetic effects of glucokinase regulatory protein small-molecule disruptorsDavid J Lloyd, David J St Jean, Robert J M Kurzeja, et al.
Nature Cancer|December 27, 2023
Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancersMarc Payton, Brian Belmontes, Kelly Hanestad, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of β-SecretaseMatthew R Kaller, Scott S Harried, Brian Albrecht, et al.
Ebiomedicine|June 5, 2019
Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Ca<sub>v</sub>3.2 T-type voltage-gated calcium channels and Ca<sup>2+</sup> influxHugo Jimenez, Minghui Wang, Jacquelyn W Zimmerman, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2015
Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's diseaseJian Jeffrey Chen, Qingyian Liu, Chester Yuan, et al.
Journal of Medicinal Chemistry|April 4, 2012
Design and preparation of a potent series of hydroxyethylamine containing β-secretase inhibitors that demonstrate robust reduction of central β-amyloidMatthew M Weiss, Toni Williamson, Safura Babu-Khan, et al.
Pageof 51